Careers
Explore
Clinical Trials - Patent Laws
The government of India passed a Patent Law in 1970, recognizing only patents on processes and not products , thus enabling pharmaceutical companies to use alternative methods to produce cheap " generic " copies of
After joining with the World Trade Organization in 1995 India made changes in its patent law again and brought it in line with International laws in January 2005. This new bill recognizes both product and process patents. According to the law India will also offer 10-year tax concessions on revenue to companies making Research & Development (R& D) investments in India . These incentives are envisaged to cause a substantial boost and increase in R&D activities of both Multinational and Indian Pharmaceutical companies.
I simply want to mention I am just beginner to weblog and honestly enjoyed your page. Likely I’m want to bookmark your blog post . You absolutely have good article content. generic buspar
Hi everyone. I need some guidance from all Clinical Research experts. I want to pursue a course : "Masters in Clinical Research : MSCR" offered by ICRI-MUSC. It is a 2 year course, 1st year course by ICRI Global Research and 2nd year course by Medical University of South Carolina. Is this a genuine course or some sort of gamble? Please give your valuable guidance. I have completed my MSc in Biochemistry this year in India.
CLINICAL RESEARCH IS ADVANCING DAY BY DAY AS THE NEW FORM OF VIRUSES STAGES ON THIS WORLD EVERY OTHER DAY ... STUDY OF CLINICAL RESEARCH WILL HAVE A GTREAT CAREER
Yes, clinical research is a growing industry in India at the moment. I am a BSc Biochem and want to make my career in this field. I recently joined James Lind Institute for my clinical research course and I hope to get placed somewhere soon.
Rahul Jain
There is a need of good clinical researcher professionals as India is going to be major hub of clinical trial industry. This can be achieved by educating medical professionals, researchers and graduates on Good Clinical Practice, Ethical conduct of the trial, discouraging fabrication of data and following timelines.